Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study)
Advanced Science · 2025-09 · 12 (33)
DOI: 10.1002/advs.202417728 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Advanced Science, online erschienen am 28.05.2025. Verfasst von Shuyue Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, 100191, China. Hauptthemen laut MEDLINE: Nucleotides, Aging, Dietary Supplements. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhen-ao Group Co., Ltd. (Dalian, China).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Aging impairs nutrient metabolism and accelerates biological aging, negatively affecting health and longevity. The Targeting Aging and Longevity with Exogenous Nucleotides (TALENTs) trial (ClinicalTrials.gov: NCT05243108) aimed to explore whether nucleotides (NTs) supplementation can delay biological aging and improve health outcomes in the elderly. The trial is a 19‐week, double‐blind, randomized, placebo‐controlled study in Chengdu, China, with 121 participants (60–70 years). Participants are randomly assigned to either NTs (1.2 g day −1 ) or placebo group (1:1). The results of primary outcomes showed that NTs had significantly greater reduction in median DNA methylation age compared to placebo over 19 weeks (β = −3.08 years, 95% CI: −5.07 to −1.10, P = 0.0023), with a trend toward reduction observed over 11 weeks (β = −1.94 years, 95% CI: −4.32 to 0.45, P = 0.11); whereas no significant difference changes of leukocyte telomere length are showed between groups (week 11: β = 0.09, 95% CI: −0.10 to 0.29, P = 0.36; week 19: β = 0.12, 95% CI: ‐0.05 to 0.28, P = 0.18). Insulin sensitivity improved in the NTs group, with a significant reduction in HOMA‐IR over 19 weeks (β = −0.45, 95% CI: −0.86 to −0.04, P = 0.033). No severe adverse events or significant changes in safety indicators are reported. Together, our findings establish that NTs may delay biological aging and improve insulin sensitivity with a well‐tolerated safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, 100191, China.
- Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Peking University, Beijing, 100191, China.
ORCID-Profile: Meihong Xu
Förderung
- Zhen-ao Group Co., Ltd. (Dalian, China)
Zitieren
APA
Wang, S., Song, L., Fan, R., Chen, Q., Fu, R., You, M., Wu, Y., Cai, M., Li, Y., & Xu, M. (2025). Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study). Advanced Science, 12(33). https://doi.org/10.1002/advs.202417728
Vancouver
Wang S, Song L, Fan R, Chen Q, Fu R, You M, et al. Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study). Advanced Science. 2025;12(33). doi:10.1002/advs.202417728
BibTeX
@article{Wang2025,
author = {Wang, Shuyue and Song, Lixia and Fan, Rui and Chen, Qianqian and Fu, Ruisheng and You, Mei and Wu, Yuxiao and Cai, Meng and Li, Yong and Xu, Meihong},
title = {Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study)},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {33},
doi = {10.1002/advs.202417728}
}
EUVIMED